Mature cDC1 cells are the most potent inducers of anticancer immunity as they cross‐present tumor antigens to CD8+ T cells [139, 140] while cDC2 primarily work by presenting exogenous antigens to CD4+ T cells for the initiation of T helper cell differentiation [141]. This evidence concerns the gene CD4 and neoplasm.